Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Sun Pharma posts lower quarterly profit on one-time acquisition-related charge

India's Sun Pharma posts lower quarterly profit on one-time acquisition-related charge 

- India's Sun Pharmaceutical Industries SUN.NS reported a drop in second-quarter profit on Friday, dragged by a one-time charge related to its acquisition of Organon.

Consolidated net profit fell to 19.89 billion rupees ($209.31 million) in the quarter ended September 30 from 31.18 billion rupees a year earlier.

The drugmaker booked a one-time charge of 12.69 billion rupees, largely comprising acquisition-related costs for its planned purchase of Organon, along with provisions linked to India's new labour code framework.



($1 = 95.0250 Indian rupees)


(Reporting by Kashish Tandon in Bengaluru; Editing by Jochelle Mendonca)

((Kashish.Tandon@thomsonreuters.com; 8800437922;))

Recent news on Sun Pharmaceutical Industries

See all news